_id
695fb311c2e91020a7bd4128
Ticker
0DTF.LSE
Name
Boiron S.A.
Exchange
LSE
Address
2, avenue de l?Ouest Lyonnais, Messimy, France, 69510
Country
UK
Sector
Industry
Currency
EUR
Website
https://www.boiron.fr
Description
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary, proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; and Sédatif PC to treat anxiety and emotional, and minor sleep disorders. The company's homeopathic medicines also comprise Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; and Homéovox for vocal disorders. In addition, it provides dietary supplement; Dermoplasmine stick, baume, and mousse to treat dry lips and skin; Mag' Nuit, a formula to fall asleep; Arnitrosium for joint pain; Castor Equi Boiron ointment for treatment of cracked skin; and Storinyl, a syrup to treat colds. Further, it offers herbal medicines, such as Canephron to increase the amount of urine and to improve urinary elimination; moisturizing baby milk; and medical devices, including a range of COVID self-tests and rapid antigenic tests. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.
Last Close
30.2
Volume
1
Current Price
30.2
Change
0.6
Last Updated
2026-01-08T13:37:21.039Z
Ipo Date
-
Market Cap
507284512
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
245647000
Cost Of Revenue
64589000
Gross Profit
181058000
Operating Expenses
165638000
Operating Income
15420000
Interest Expense
441000
Pretax Income
14814000
Net Income
11364000
Eps
0.6545225208102049
Dividends Per Share
20835000
Shares Outstanding
17603300
Income Tax Expense
3449000
EBITDA
30442000
Operating Margin
6.277300353759663
Total Other Income Expense Net
-606000
Cash
62447000
Short Term Investments
-
Receivables
93573000
Inventories
104494000
Total Current Assets
267176000
Property Plant Equipment
139375000
Total Assets
561589000
Payables
31981000
Short Term Debt
3689000
Long Term Debt
-
Total Liabilities
192466000
Equity
369104000
Bs_currency_symbol
-
Depreciation
15186000
Change In Working Capital
-1245000
Cash From Operations
28126000
Capital Expenditures
3517000
Cash From Investing
-8103000
Cash From Financing
-23617000
Net Change In Cash
-2262000
Cf_currency_symbol
-
PE
0.1853
PB
1.4205771408600285
ROE
3.078807057089601
ROA
2.0235439084455003
FCF
24609000
Fcf Percent
0.10018034008149906
Piotroski FScore
4
Health Score
60
Deep Value Investing Score
8.5
Defensive Investing Score
6.5
Dividend Investing Score
3.5
Economic Moat Investing Score
7.3
Garp Investing Score
6
Growth Investing Score
5
Momentum Investing Score
7
Net Net Investing Score
4
Quality Investing Score
6
Value Investing Score
7.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
245647000
Quarters > 0 > income Statement > cost Of Revenue
64589000
Quarters > 0 > income Statement > gross Profit
181058000
Quarters > 0 > income Statement > operating Expenses
165638000
Quarters > 0 > income Statement > operating Income
15420000
Quarters > 0 > income Statement > interest Expense
441000
Quarters > 0 > income Statement > pretax Income
14814000
Quarters > 0 > income Statement > net Income
11364000
Quarters > 0 > income Statement > eps
0.6545225208102049
Quarters > 0 > income Statement > dividends Per Share
20835000
Quarters > 0 > income Statement > shares Outstanding
17362275
Quarters > 0 > income Statement > income Tax Expense
3449000
Quarters > 0 > income Statement > EBITDA
30442000
Quarters > 0 > income Statement > operating Margin
6.277300353759663
Quarters > 0 > income Statement > total Other Income Expense Net
-606000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
62447000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
93573000
Quarters > 0 > balance Sheet > inventories
104494000
Quarters > 0 > balance Sheet > total Current Assets
267176000
Quarters > 0 > balance Sheet > property Plant Equipment
139375000
Quarters > 0 > balance Sheet > total Assets
561589000
Quarters > 0 > balance Sheet > payables
31981000
Quarters > 0 > balance Sheet > short Term Debt
3689000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
192466000
Quarters > 0 > balance Sheet > equity
369104000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
11364000
Quarters > 0 > cash Flow > depreciation
15186000
Quarters > 0 > cash Flow > change In Working Capital
-1245000
Quarters > 0 > cash Flow > cash From Operations
28126000
Quarters > 0 > cash Flow > capital Expenditures
3517000
Quarters > 0 > cash Flow > cash From Investing
-8103000
Quarters > 0 > cash Flow > cash From Financing
-23617000
Quarters > 0 > cash Flow > net Change In Cash
-2262000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
0.6545225208102049
Quarters > 0 > ratios > PB
1.4205771408600285
Quarters > 0 > ratios > ROE
3.078807057089601
Quarters > 0 > ratios > ROA
2.0235439084455003
Quarters > 0 > ratios > FCF
24609000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.10018034008149906
Quarters > 0 > health Score
60
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
259211000
Quarters > 1 > income Statement > cost Of Revenue
68146000
Quarters > 1 > income Statement > gross Profit
191065000
Quarters > 1 > income Statement > operating Expenses
180203000
Quarters > 1 > income Statement > operating Income
31387000
Quarters > 1 > income Statement > interest Expense
559000
Quarters > 1 > income Statement > pretax Income
9626000
Quarters > 1 > income Statement > net Income
8004000
Quarters > 1 > income Statement > eps
0.46099949459388245
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
17362275
Quarters > 1 > income Statement > income Tax Expense
1620000
Quarters > 1 > income Statement > EBITDA
25800000
Quarters > 1 > income Statement > operating Margin
12.108668227814407
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
64709000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
109987000
Quarters > 1 > balance Sheet > inventories
101110000
Quarters > 1 > balance Sheet > total Current Assets
280993000
Quarters > 1 > balance Sheet > property Plant Equipment
143479000
Quarters > 1 > balance Sheet > total Assets
576331000
Quarters > 1 > balance Sheet > payables
37164000
Quarters > 1 > balance Sheet > short Term Debt
4519000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
198148000
Quarters > 1 > balance Sheet > equity
378145000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
8004000
Quarters > 1 > cash Flow > depreciation
15615000
Quarters > 1 > cash Flow > change In Working Capital
-11574000
Quarters > 1 > cash Flow > cash From Operations
27674000
Quarters > 1 > cash Flow > capital Expenditures
4408000
Quarters > 1 > cash Flow > cash From Investing
-8179000
Quarters > 1 > cash Flow > cash From Financing
-3073000
Quarters > 1 > cash Flow > net Change In Cash
11383000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
0.46099949459388245
Quarters > 1 > ratios > PB
1.3866128204789168
Quarters > 1 > ratios > ROE
2.1166483756231074
Quarters > 1 > ratios > ROA
1.3887852640236253
Quarters > 1 > ratios > FCF
23266000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.0897569933374741
Quarters > 1 > health Score
57
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
228348000
Quarters > 2 > income Statement > cost Of Revenue
60650000
Quarters > 2 > income Statement > gross Profit
167698000
Quarters > 2 > income Statement > operating Expenses
162824000
Quarters > 2 > income Statement > operating Income
4874000
Quarters > 2 > income Statement > interest Expense
660000
Quarters > 2 > income Statement > pretax Income
4450000
Quarters > 2 > income Statement > net Income
3331000
Quarters > 2 > income Statement > eps
0.19185273819243157
Quarters > 2 > income Statement > dividends Per Share
23439000
Quarters > 2 > income Statement > shares Outstanding
17362275
Quarters > 2 > income Statement > income Tax Expense
1121000
Quarters > 2 > income Statement > EBITDA
22738000
Quarters > 2 > income Statement > operating Margin
2.1344614360537424
Quarters > 2 > income Statement > total Other Income Expense Net
-424000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
53326000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
77702000
Quarters > 2 > balance Sheet > inventories
99869000
Quarters > 2 > balance Sheet > total Current Assets
255651000
Quarters > 2 > balance Sheet > property Plant Equipment
147046000
Quarters > 2 > balance Sheet > total Assets
557654000
Quarters > 2 > balance Sheet > payables
37201000
Quarters > 2 > balance Sheet > short Term Debt
6871000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
184681000
Quarters > 2 > balance Sheet > equity
372937000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
3331000
Quarters > 2 > cash Flow > depreciation
14610000
Quarters > 2 > cash Flow > change In Working Capital
10655000
Quarters > 2 > cash Flow > cash From Operations
14494000
Quarters > 2 > cash Flow > capital Expenditures
3991000
Quarters > 2 > cash Flow > cash From Investing
-10181000
Quarters > 2 > cash Flow > cash From Financing
-27416000
Quarters > 2 > cash Flow > net Change In Cash
-20718000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
0.19185273819243157
Quarters > 2 > ratios > PB
1.4059766260789355
Quarters > 2 > ratios > ROE
0.8931803494960274
Quarters > 2 > ratios > ROA
0.5973237885857539
Quarters > 2 > ratios > FCF
10503000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.04599558568500709
Quarters > 2 > health Score
55
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
253365000
Quarters > 3 > income Statement > cost Of Revenue
70197000
Quarters > 3 > income Statement > gross Profit
183168000
Quarters > 3 > income Statement > operating Expenses
153225000
Quarters > 3 > income Statement > operating Income
24508000
Quarters > 3 > income Statement > interest Expense
454000
Quarters > 3 > income Statement > pretax Income
26761000
Quarters > 3 > income Statement > net Income
20359000
Quarters > 3 > income Statement > eps
1.172599721372935
Quarters > 3 > income Statement > dividends Per Share
179873000
Quarters > 3 > income Statement > shares Outstanding
17362276
Quarters > 3 > income Statement > income Tax Expense
7152000
Quarters > 3 > income Statement > EBITDA
48157000
Quarters > 3 > income Statement > operating Margin
9.673001401140645
Quarters > 3 > income Statement > total Other Income Expense Net
2253000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
74044000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
86954000
Quarters > 3 > balance Sheet > inventories
96767000
Quarters > 3 > balance Sheet > total Current Assets
286214000
Quarters > 3 > balance Sheet > property Plant Equipment
151664000
Quarters > 3 > balance Sheet > total Assets
590201000
Quarters > 3 > balance Sheet > payables
44630000
Quarters > 3 > balance Sheet > short Term Debt
7057000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
198701000
Quarters > 3 > balance Sheet > equity
393661000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
20359000
Quarters > 3 > cash Flow > depreciation
19790000
Quarters > 3 > cash Flow > change In Working Capital
-2461000
Quarters > 3 > cash Flow > cash From Operations
32564999
Quarters > 3 > cash Flow > capital Expenditures
5635000
Quarters > 3 > cash Flow > cash From Investing
-9383000
Quarters > 3 > cash Flow > cash From Financing
-182464000
Quarters > 3 > cash Flow > net Change In Cash
-158217000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
1.172599721372935
Quarters > 3 > ratios > PB
1.331960075293209
Quarters > 3 > ratios > ROE
5.171708652876459
Quarters > 3 > ratios > ROA
3.4495027965049196
Quarters > 3 > ratios > FCF
26929999
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.10628934146389596
Quarters > 3 > health Score
63
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
487559000
Annuals > 0 > income Statement > cost Of Revenue
128796000
Annuals > 0 > income Statement > gross Profit
358763000
Annuals > 0 > income Statement > operating Expenses
343027000
Annuals > 0 > income Statement > operating Income
15736000
Annuals > 0 > income Statement > interest Expense
1615000
Annuals > 0 > income Statement > pretax Income
14576000
Annuals > 0 > income Statement > net Income
11336000
Annuals > 0 > income Statement > eps
0.6529098289250689
Annuals > 0 > income Statement > dividends Per Share
23439000
Annuals > 0 > income Statement > shares Outstanding
17362275
Annuals > 0 > income Statement > income Tax Expense
2288000
Annuals > 0 > income Statement > EBITDA
45463000
Annuals > 0 > income Statement > operating Margin
3.2275068248150482
Annuals > 0 > income Statement > total Other Income Expense Net
-1160000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
64709000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
109987000
Annuals > 0 > balance Sheet > inventories
101110000
Annuals > 0 > balance Sheet > total Current Assets
280993000
Annuals > 0 > balance Sheet > property Plant Equipment
143479000
Annuals > 0 > balance Sheet > total Assets
576331000
Annuals > 0 > balance Sheet > payables
37164000
Annuals > 0 > balance Sheet > short Term Debt
4519000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
198148000
Annuals > 0 > balance Sheet > equity
378145000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
11336000
Annuals > 0 > cash Flow > depreciation
30226000
Annuals > 0 > cash Flow > change In Working Capital
-9221000
Annuals > 0 > cash Flow > cash From Operations
39533000
Annuals > 0 > cash Flow > capital Expenditures
8399000
Annuals > 0 > cash Flow > cash From Investing
-18360000
Annuals > 0 > cash Flow > cash From Financing
-27854000
Annuals > 0 > cash Flow > net Change In Cash
-9335000
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
0.6529098289250689
Annuals > 0 > ratios > PB
1.3866128204789168
Annuals > 0 > ratios > ROE
2.9977918523317775
Annuals > 0 > ratios > ROA
1.9669252564932305
Annuals > 0 > ratios > FCF
31134000
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.06385688706392458
Annuals > 0 > health Score
56
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
493248000
Annuals > 1 > income Statement > cost Of Revenue
135165000
Annuals > 1 > income Statement > gross Profit
358083000
Annuals > 1 > income Statement > operating Expenses
315794000
Annuals > 1 > income Statement > operating Income
42290000
Annuals > 1 > income Statement > interest Expense
1191000
Annuals > 1 > income Statement > pretax Income
46851000
Annuals > 1 > income Statement > net Income
35827000
Annuals > 1 > income Statement > eps
2.063503162210459
Annuals > 1 > income Statement > dividends Per Share
198969000
Annuals > 1 > income Statement > shares Outstanding
17362222
Annuals > 1 > income Statement > income Tax Expense
12911000
Annuals > 1 > income Statement > EBITDA
73667000
Annuals > 1 > income Statement > operating Margin
8.57378032957052
Annuals > 1 > income Statement > total Other Income Expense Net
4561000
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
74044000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
86954000
Annuals > 1 > balance Sheet > inventories
96767000
Annuals > 1 > balance Sheet > total Current Assets
286214000
Annuals > 1 > balance Sheet > property Plant Equipment
151665000
Annuals > 1 > balance Sheet > total Assets
590201000
Annuals > 1 > balance Sheet > payables
44630000
Annuals > 1 > balance Sheet > short Term Debt
7057000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
198701000
Annuals > 1 > balance Sheet > equity
393661000
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
35827000
Annuals > 1 > cash Flow > depreciation
25625000
Annuals > 1 > cash Flow > change In Working Capital
4559000
Annuals > 1 > cash Flow > cash From Operations
45491000
Annuals > 1 > cash Flow > capital Expenditures
18025000
Annuals > 1 > cash Flow > cash From Investing
-22926000
Annuals > 1 > cash Flow > cash From Financing
-198413000
Annuals > 1 > cash Flow > net Change In Cash
-177644000
Annuals > 1 > cash Flow > currency_symbol
-
Annuals > 1 > ratios > PE
2.063503162210459
Annuals > 1 > ratios > PB
1.331955932642553
Annuals > 1 > ratios > ROE
9.10097774481089
Annuals > 1 > ratios > ROA
6.070304862241847
Annuals > 1 > ratios > FCF
27466000
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
0.05568395614376541
Annuals > 1 > health Score
64
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
534239000
Annuals > 2 > income Statement > cost Of Revenue
154513000
Annuals > 2 > income Statement > gross Profit
379726000
Annuals > 2 > income Statement > operating Expenses
316278000
Annuals > 2 > income Statement > operating Income
55828000
Annuals > 2 > income Statement > interest Expense
1537000
Annuals > 2 > income Statement > pretax Income
57965000
Annuals > 2 > income Statement > net Income
44673000
Annuals > 2 > income Statement > eps
2.569012634357325
Annuals > 2 > income Statement > dividends Per Share
16502000
Annuals > 2 > income Statement > shares Outstanding
17389171
Annuals > 2 > income Statement > income Tax Expense
13685000
Annuals > 2 > income Statement > EBITDA
91330000
Annuals > 2 > income Statement > operating Margin
10.450004585962462
Annuals > 2 > income Statement > total Other Income Expense Net
2137000
Annuals > 2 > income Statement > currency_symbol
-
Annuals > 2 > balance Sheet > cash
250945000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
100536000
Annuals > 2 > balance Sheet > inventories
96924000
Annuals > 2 > balance Sheet > total Current Assets
477833000
Annuals > 2 > balance Sheet > property Plant Equipment
160465000
Annuals > 2 > balance Sheet > total Assets
789493000
Annuals > 2 > balance Sheet > payables
48250000
Annuals > 2 > balance Sheet > short Term Debt
5428000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
232147000
Annuals > 2 > balance Sheet > equity
557616000
Annuals > 2 > balance Sheet > currency_symbol
-
Annuals > 2 > cash Flow > net Income
44673000
Annuals > 2 > cash Flow > depreciation
17214000
Annuals > 2 > cash Flow > change In Working Capital
5961000
Annuals > 2 > cash Flow > cash From Operations
58690000
Annuals > 2 > cash Flow > capital Expenditures
18591000
Annuals > 2 > cash Flow > cash From Investing
-15277000
Annuals > 2 > cash Flow > cash From Financing
-28986000
Annuals > 2 > cash Flow > net Change In Cash
15578000
Annuals > 2 > cash Flow > currency_symbol
-
Annuals > 2 > ratios > PE
2.569012634357325
Annuals > 2 > ratios > PB
0.9417824527990588
Annuals > 2 > ratios > ROE
8.01142721873117
Annuals > 2 > ratios > ROA
5.658441556796577
Annuals > 2 > ratios > FCF
40099000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.07505816685041714
Annuals > 2 > health Score
68
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
455201000
Annuals > 3 > income Statement > cost Of Revenue
127579000
Annuals > 3 > income Statement > gross Profit
327622000
Annuals > 3 > income Statement > operating Expenses
280780000
Annuals > 3 > income Statement > operating Income
37430000
Annuals > 3 > income Statement > interest Expense
537000
Annuals > 3 > income Statement > pretax Income
44847000
Annuals > 3 > income Statement > net Income
28556000
Annuals > 3 > income Statement > eps
1.6302373286669436
Annuals > 3 > income Statement > dividends Per Share
16643000
Annuals > 3 > income Statement > shares Outstanding
17516468
Annuals > 3 > income Statement > income Tax Expense
16288000
Annuals > 3 > income Statement > EBITDA
78755000
Annuals > 3 > income Statement > operating Margin
8.222741162695161
Annuals > 3 > income Statement > total Other Income Expense Net
7417000
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
234504000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
126521000
Annuals > 3 > balance Sheet > inventories
85556000
Annuals > 3 > balance Sheet > total Current Assets
452364000
Annuals > 3 > balance Sheet > property Plant Equipment
171400000
Annuals > 3 > balance Sheet > total Assets
770700000
Annuals > 3 > balance Sheet > payables
44180000
Annuals > 3 > balance Sheet > short Term Debt
4887000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
238929000
Annuals > 3 > balance Sheet > equity
531735000
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
28556000
Annuals > 3 > cash Flow > depreciation
18124000
Annuals > 3 > cash Flow > change In Working Capital
-18018000
Annuals > 3 > cash Flow > cash From Operations
33317000
Annuals > 3 > cash Flow > capital Expenditures
20418000
Annuals > 3 > cash Flow > cash From Investing
-11921000
Annuals > 3 > cash Flow > cash From Financing
-21995000
Annuals > 3 > cash Flow > net Change In Cash
-231000
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
1.6302373286669436
Annuals > 3 > ratios > PB
0.9948514459270125
Annuals > 3 > ratios > ROE
5.370344250425494
Annuals > 3 > ratios > ROA
3.7052030621512912
Annuals > 3 > ratios > FCF
12899000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
0.028336932475983137
Annuals > 3 > health Score
59
Valuation > metrics > PE
0.1853
Valuation > metrics > PB
1.4205771408600285
Valuation > final Score
100
Valuation > verdict
49.1% Undervalued
Profitability > metrics > ROE
3.078807057089601
Profitability > metrics > ROA
4.253376051741174
Profitability > metrics > Net Margin
0.04626150533082024
Profitability > final Score
26
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.5214411114482639
Risk > metrics > Interest Coverage
34.965986394557824
Risk > final Score
88
Risk > verdict
Low
Liquidity > metrics > Current Ratio
7.490215867675918
Liquidity > metrics > Quick Ratio
4.560751331651248
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
100
Prev Valuations > 1
100
Prev Valuations > 2
100
Prev Profitabilities > 0
17
Prev Profitabilities > 1
8
Prev Profitabilities > 2
44
Prev Risks > 0
88
Prev Risks > 1
90
Prev Risks > 2
88
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:13:10.456Z
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary, proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; and Sédatif PC to treat anxiety and emotional, and minor sleep disorders. The company's homeopathic medicines also comprise Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; and Homéovox for vocal disorders. In addition, it provides dietary supplement; Dermoplasmine stick, baume, and mousse to treat dry lips and skin; Mag' Nuit, a formula to fall asleep; Arnitrosium for joint pain; Castor Equi Boiron ointment for treatment of cracked skin; and Storinyl, a syrup to treat colds. Further, it offers herbal medicines, such as Canephron to increase the amount of urine and to improve urinary elimination; moisturizing baby milk; and medical devices, including a range of COVID self-tests and rapid antigenic tests. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.
Stock Price
€0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Medium
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Boiron S.A.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2025-06-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.